JP7470412B2 - Coronavirus killer - Google Patents
Coronavirus killer Download PDFInfo
- Publication number
- JP7470412B2 JP7470412B2 JP2020166179A JP2020166179A JP7470412B2 JP 7470412 B2 JP7470412 B2 JP 7470412B2 JP 2020166179 A JP2020166179 A JP 2020166179A JP 2020166179 A JP2020166179 A JP 2020166179A JP 7470412 B2 JP7470412 B2 JP 7470412B2
- Authority
- JP
- Japan
- Prior art keywords
- propolis
- mass
- coronavirus
- less
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000004176 Alphacoronavirus Species 0.000 title 1
- 241000241413 Propolis Species 0.000 claims description 69
- 229940069949 propolis Drugs 0.000 claims description 69
- 241000711573 Coronaviridae Species 0.000 claims description 43
- 239000004480 active ingredient Substances 0.000 claims description 7
- 239000000047 product Substances 0.000 description 19
- 239000007788 liquid Substances 0.000 description 17
- 239000002537 cosmetic Substances 0.000 description 15
- 239000000284 extract Substances 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 14
- 235000013305 food Nutrition 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000003139 biocide Substances 0.000 description 13
- 239000000203 mixture Substances 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 10
- 239000007787 solid Substances 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000008187 granular material Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 5
- 230000002147 killing effect Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 241000256844 Apis mellifera Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 108700005077 Viral Genes Proteins 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 239000000469 ethanolic extract Substances 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- KABCFARPAMSXCC-JXMROGBWSA-N (e)-3-[4-hydroxy-3,5-bis(3-methylbut-2-enyl)phenyl]prop-2-enoic acid Chemical compound CC(C)=CCC1=CC(\C=C\C(O)=O)=CC(CC=C(C)C)=C1O KABCFARPAMSXCC-JXMROGBWSA-N 0.000 description 3
- 241001551937 Apis mellifera scutellata Species 0.000 description 3
- 241001135549 Porcine epidemic diarrhea virus Species 0.000 description 3
- KABCFARPAMSXCC-UHFFFAOYSA-N artepillin C Natural products CC(C)=CCC1=CC(C=CC(O)=O)=CC(CC=C(C)C)=C1O KABCFARPAMSXCC-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000003253 viricidal effect Effects 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 2
- 241000256836 Apis Species 0.000 description 2
- 241000132016 Baccharis Species 0.000 description 2
- 239000004278 EU approved seasoning Substances 0.000 description 2
- 244000166124 Eucalyptus globulus Species 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 241001237961 Amanita rubescens Species 0.000 description 1
- 241000256837 Apidae Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001678559 COVID-19 virus Species 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 241001249666 Clusia <angiosperm> Species 0.000 description 1
- 240000006766 Cornus mas Species 0.000 description 1
- 235000003363 Cornus mas Nutrition 0.000 description 1
- 208000001528 Coronaviridae Infections Diseases 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 241001269524 Dura Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000004533 Hesperis matronalis Species 0.000 description 1
- 235000015847 Hesperis matronalis Nutrition 0.000 description 1
- 244000309467 Human Coronavirus Species 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 241000519695 Ilex integra Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000337007 Oceania Species 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 238000009341 apiculture Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 235000011950 custard Nutrition 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- -1 flavorings Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000019988 mead Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940114496 olive leaf extract Drugs 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229940109529 pomegranate extract Drugs 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000001331 rosmarinus officinalis leaf Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000008257 shaving cream Substances 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000008924 yoghurt drink Nutrition 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
本発明は、殺コロナウイルス剤に関する。 The present invention relates to a coronavirus killing agent.
インフルエンザウイルス及びコロナウイルスに対するプロポリスの抗ウイルス効果の可能性について報告されている(例えば、非特許文献1)。 The possible antiviral effects of propolis against influenza viruses and coronaviruses have been reported (e.g., Non-Patent Document 1).
しかしながら、プロポリスによるコロナウイルスに対する殺ウイルス効果はこれまで確認されていない。 However, the virucidal effect of propolis against coronaviruses has not been confirmed so far.
本発明は、新規な殺コロナウイルス剤を提供することを目的とする。 The present invention aims to provide a novel coronavirus killing agent.
本発明の殺コロナウイルス剤は、プロポリスを有効成分として含む。 The coronavirus killing agent of the present invention contains propolis as an active ingredient.
上記殺コロナウイルス剤において、対象コロナウイルスは、豚感染性コロナウイルスであってよい。 In the above-mentioned coronavirus killing agent, the target coronavirus may be a porcine coronavirus.
本発明により、新規な殺コロナウイルス剤が提供される。 The present invention provides a novel coronavirus killing agent.
以下、本発明の好適な実施形態について詳細に説明する。ただし、本発明は以下の実施形態に限定されるものではない。 The following describes in detail preferred embodiments of the present invention. However, the present invention is not limited to the following embodiments.
本発明の殺コロナウイルス剤は、有効成分としてプロポリスを含む。本実施形態に係る殺コロナウイルス剤は、プロポリスを含むため、殺コロナウイルス作用を有する。 The coronavirus killing agent of the present invention contains propolis as an active ingredient. The coronavirus killing agent according to this embodiment contains propolis, and therefore has a coronavirus killing effect.
本明細書において、殺コロナウイルスとは、コロナウイルス自体に直接作用してウイルスを殺すことを指す。殺コロナウイルスとは、具体的には例えば、対象のコロナウイルスを不活化させること、分解することであってよい。
本明細書でいう殺ウイルスとは、ウイルスが体内に侵入した後にウイルスの増殖を抑制する作用である「抗ウイルス」とは異なるものである。
As used herein, the term "coronavirus killing" refers to killing the coronavirus by directly acting on the coronavirus itself. Specifically, the term "coronavirus killing" may refer to, for example, inactivating or decomposing the target coronavirus.
The term "viricidal" as used herein is different from "antiviral," which is the action of suppressing the proliferation of a virus after it has invaded the body.
本実施形態に係る殺コロナウイルス剤によるウイルス減少率は、例えば、90%以上、95%以上、98%以上又は99%以上であってよい。 The virus reduction rate by the coronavirusicide of this embodiment may be, for example, 90% or more, 95% or more, 98% or more, or 99% or more.
本実施形態に係る殺コロナウイルス剤は殺コロナウイルス作用を有するため、例えば、コロナウイルス感染症に対する予防、コロナウイルス拡散に対する予防等に用いることもできる。 Since the coronavirusicidal agent according to this embodiment has a coronavirusicidal effect, it can also be used, for example, to prevent coronavirus infection and the spread of coronavirus.
本実施形態に係る殺コロナウイルス剤の対象であるコロナウイルスは、例えば、豚感染性コロナウイルス(PEDV)、ヒトコロナウイルス(例えば、229E、NL63、HKU1、OC43)、SARSコロナウイルス、MERSコロナウイルス、又はSARSコロナウイルス2であってよい。 The coronavirus that is the target of the coronavirusicidal agent of this embodiment may be, for example, porcine infectious coronavirus (PEDV), human coronavirus (e.g., 229E, NL63, HKU1, OC43), SARS coronavirus, MERS coronavirus, or SARS coronavirus 2.
(プロポリス)
プロポリスは、例えば、常法に従い養蜂産品として入手することができる。プロポリスは、アレクリン由来、ユーカリ由来、ポプラ由来、クルシア属植物由来等、いずれの植物由来であってもよい。生理活性の高さの観点から、アレクリン由来のプロポリスが好ましい。アレクリンはキク科バッカリス属のバッカリス・ドゥラクンクリフォリアである。
(Propolis)
Propolis can be obtained, for example, as a beekeeping product according to a conventional method. Propolis may be derived from any plant, such as Alecrin, Eucalyptus, Poplar, Clusia, etc. From the viewpoint of high physiological activity, Alecrin-derived propolis is preferred. Alecrin is Baccharis dura unclifolia, which belongs to the Baccharis genus of the Asteraceae family.
プロポリスは、例えば、日本産、ブラジル産、中国産、ヨーロッパ諸国産、オセアニア産、アメリカ産等であってよい。ブラジル産プロポリスは、主にアレクリンを由来とする。 Propolis may be, for example, from Japan, Brazil, China, European countries, Oceania, America, etc. Brazilian propolis is mainly derived from alecrin.
プロポリスは、ブラウン、レッド、イエロー、グリーン、スーパーグリーン、ウルトラグリーン等のいずれのランクであってもよく、これらの中でもグリーン、スーパーグリーン又はウルトラグリーンランクのプロポリスが好ましい。これらのランクはプロポリス中のアルテピリンC含有量によって定められる。アルテピリンCが3質量%以上であるものをグリーンプロポリスと称する。プロポリス中のアルテピリンC含有量は5質量%以上であることが好ましく、8質量%以上であることがより好ましい。 Propolis may be of any rank, such as brown, red, yellow, green, super green, or ultra green, and among these, propolis of the green, super green, or ultra green rank is preferred. These ranks are determined by the amount of artepillin C in the propolis. Propolis containing 3% or more by mass of artepillin C is called green propolis. The amount of artepillin C in the propolis is preferably 5% or more by mass, and more preferably 8% or more by mass.
プロポリスは、ミツバチ科ミツバチ属に属する蜂由来のものであることが好ましく、ミツバチ属の中でもセイヨウミツバチ由来のものであることが好ましい。セイヨウミツバチには、24~28の亜種があるとされており、いずれの亜種由来のプロポリスを用いてもよい。特に、セイヨウミツバチの亜種の1つであるアフリカミツバチ(A.mellifera scutellata)と他のセイヨウミツバチのヨーロッパ産亜種との交雑種であるアフリカ蜂化ミツバチ由来のプロポリスを用いることが好ましい。 Propolis is preferably derived from bees belonging to the genus Apis of the family Apidae, and among the genus Apis, it is preferable to use propolis derived from the Western honeybee. There are said to be 24 to 28 subspecies of the Western honeybee, and propolis derived from any subspecies may be used. In particular, it is preferable to use propolis derived from the African honeybee (A. mellifera scutellata), which is a subspecies of the Western honeybee, and the African honeybee, which is a hybrid between another European subspecies of the Western honeybee.
プロポリスは、例えば、プロポリス原塊であってもよく、プロポリス原塊に何らかの処理を施したプロポリス処理物であってもよい。プロポリス処理物は、例えば、プロポリス原塊に、粉砕、抽出、抽出物の濃縮又は粉末化、粉末の造粒等の処理が施されたものであってよく、抽出後に残る抽出残渣であってもよい。すなわちプロポリス処理物は、例えば、プロポリスの粉砕物、抽出物、濃縮抽出物、抽出物粉末、抽出物顆粒、抽出残渣等であってよい。抽出は、例えば、水抽出、親水性有機溶媒抽出、超臨界抽出等であってよい。親水性有機溶媒としては、例えばエタノール、グリセリン、1,3-ブチレングリコール等が挙げられる。プロポリス抽出物は、プロポリス原塊から抽出して得られたものであってもよく、抽出後の残渣から更に抽出して得られたものであってもよい。処理方法は1つであってよく、2つ以上を組み合わせてもよい。プロポリス処理物としては、プロポリス親水性有機溶媒抽出物が、短時間で効率的にバランスよくプロポリスの有効成分が抽出されたものであるため好ましい。プロポリス処理物は、プロポリスエタノール抽出物、プロポロス水抽出物、又はプロポリス熱水抽出物であることが好ましい。また、プロポリス処理物は、プロポリスエタノール抽出物、プロポリス水抽出物、及びプロポリス熱水抽出物の組合せであってもよい。 Propolis may be, for example, raw propolis mass, or may be a processed propolis product obtained by subjecting raw propolis mass to some kind of processing. The processed propolis product may be, for example, raw propolis mass that has been subjected to processing such as pulverization, extraction, extract concentration or powderization, powder granulation, or may be the extraction residue remaining after extraction. That is, the processed propolis product may be, for example, a pulverized propolis mass, an extract, a concentrated extract, an extract powder, an extract granule, an extraction residue, or the like. The extraction may be, for example, water extraction, hydrophilic organic solvent extraction, supercritical extraction, or the like. Examples of hydrophilic organic solvents include ethanol, glycerin, and 1,3-butylene glycol. The propolis extract may be obtained by extraction from raw propolis mass, or may be obtained by further extraction from the residue after extraction. The processing method may be one, or two or more may be combined. As the processed propolis product, a hydrophilic organic solvent extract of propolis is preferable because the active ingredients of propolis are extracted efficiently and in a balanced manner in a short time. The processed propolis is preferably a propolis ethanol extract, a propolis water extract, or a propolis hot water extract. The processed propolis may also be a combination of a propolis ethanol extract, a propolis water extract, and a propolis hot water extract.
プロポリスとしては、市販品を用いてもよい。プロポリスを含む市販品は、例えば、山田養蜂場社のプロポリス300、プロポリス液30(ブラジル産)、プロポリス粒、プロポリス顆粒APC、プロポリスマイルド、プロポリスドリンク、森川健康堂社のネオプロポリス粒、プロポリス粒、プロポリス液、プロポリスマイルド液、ユーカリポリス、ラベイユ社のラベイユプロポリス(液タイプ)、ラベイユプロポリス(カプセルタイプ)、ラベイユプロポリスはちみつ等が挙げられる。 As propolis, commercially available products may be used. Examples of commercially available products containing propolis include Yamada Bee Farm's Propolis 300, Propolis Liquid 30 (made in Brazil), propolis granules, propolis granules APC, propolis mild, and propolis drink, Morikawa Kenkodo's Neo Propolis Granules, Propolis Granules, Propolis Liquid, Propolis Mild Liquid, Eucalyptus Polis, Labeille's Labeille Propolis (liquid type), Labeille Propolis (capsule type), and Labeille Propolis Honey.
上記殺コロナウイルス剤は、プロポリスの固形分量として、例えば体重60kgの成人に一日当たり1mg以上、3mg以上、5mg以上、10mg以上、20mg以上の用量で用いることができ、1000mg以下、800mg以下、500mg以下、300mg以下、100mg以下、80mg以下、50mg以下の用量で用いてもよい。 The above-mentioned coronavirus killer can be used at a dose of 1 mg or more, 3 mg or more, 5 mg or more, 10 mg or more, or 20 mg or more per day for an adult weighing 60 kg, as the solid content of propolis, and may also be used at a dose of 1000 mg or less, 800 mg or less, 500 mg or less, 300 mg or less, 100 mg or less, 80 mg or less, or 50 mg or less.
上記殺コロナウイルス剤中のプロポリスの含有量は、固形分として、剤の全量に対して、例えば、0.000000001質量%以上、0.00000001質量%以上、0.0000001質量%以上、0.000001質量%以上、0.00001質量%以上、0.0001質量%以上、0.001質量%以上、0.01質量%以上、0.1質量%以上、1質量%以上、3質量%以上、3.5質量%以上、5質量%以上、7質量%以上、10質量%以上、15質量%以上、20質量%以上、25質量%以上、30質量%以上、35質量%以上、40質量%以上、45質量%以上、50質量%以上、55質量%以上、60質量%以上、65質量%以上、70質量%以上、75質量%以上、80質量%以上、85質量%以上、90質量%以上、93質量%以上、95質量%以上、98質量%以上、99質量%以上、又は100質量%であってよい。殺コロナウイルス剤中のプロポリスの含有量は、固形分として、剤の全量に対して、例えば、100質量%以下、99質量%以下、98質量%以下、95質量%以下、93質量%以下、90質量%以下、85質量%以下、80質量%以下、75質量%以下、70質量%以下、65質量%以下、60質量%以下、55質量%以下、50質量%以下、45質量%以下、40質量%以下、35質量%以下、30質量%以下、25質量%以下、20質量%以下、15質量%以下、10質量%以下、8質量%以下、5質量%以下、3質量%以下、又は1質量%以下であってよい。 The content of propolis in the coronavirus killing agent is, as a solid content, for example, 0.000000001% by mass or more, 0.00000001% by mass or more, 0.0000001% by mass or more, 0.000001% by mass or more, 0.00001% by mass or more, 0.00001% by mass or more, 0.0001% by mass or more, 0.001% by mass or more, 0.01% by mass or more, 0.1% by mass or more, 1% by mass or more, 3% by mass or more, 3.5% by mass or more, 5% by mass or more relative to the total amount of the agent. , 7% by weight or more, 10% by weight or more, 15% by weight or more, 20% by weight or more, 25% by weight or more, 30% by weight or more, 35% by weight or more, 40% by weight or more, 45% by weight or more, 50% by weight or more, 55% by weight or more, 60% by weight or more, 65% by weight or more, 70% by weight or more, 75% by weight or more, 80% by weight or more, 85% by weight or more, 90% by weight or more, 93% by weight or more, 95% by weight or more, 98% by weight or more, 99% by weight or more, or 100% by weight. The content of propolis in the coronavirus killing agent, as a solid content, based on the total amount of the agent, may be, for example, 100% by mass or less, 99% by mass or less, 98% by mass or less, 95% by mass or less, 93% by mass or less, 90% by mass or less, 85% by mass or less, 80% by mass or less, 75% by mass or less, 70% by mass or less, 65% by mass or less, 60% by mass or less, 55% by mass or less, 50% by mass or less, 45% by mass or less, 40% by mass or less, 35% by mass or less, 30% by mass or less, 25% by mass or less, 20% by mass or less, 15% by mass or less, 10% by mass or less, 8% by mass or less, 5% by mass or less, 3% by mass or less, or 1% by mass or less.
本実施形態に係る殺コロナウイルス剤の投与対象者は、例えば健常者であってよい。 The recipient of the coronavirusicidal agent of this embodiment may be, for example, a healthy individual.
本実施形態に係る殺コロナウイルス剤は、有効成分としてのプロポリスに加えて、他の成分を更に含有していてもよい。他の成分としては、例えば、薬学的に許容される成分(例えば、賦形剤、結合材、滑沢剤、崩壊剤、乳化剤、界面活性剤、基剤、溶解補助剤、懸濁化剤)、食品として許容される成分(例えば、ミネラル類、ビタミン類、フラボノイド類、キノン類、ポリフェノール類、アミノ酸、核酸、必須脂肪酸、清涼剤、結合剤、甘味料、崩壊剤、滑沢剤、着色料、香料、安定化剤、防腐剤、徐放調整剤、界面活性剤、溶解剤、湿潤剤)を挙げることができる。 The coronavirus killing agent according to this embodiment may further contain other ingredients in addition to propolis as an active ingredient. Examples of other ingredients include pharma- ceutically acceptable ingredients (e.g., excipients, binders, lubricants, disintegrants, emulsifiers, surfactants, bases, solubilizers, and suspending agents) and food acceptable ingredients (e.g., minerals, vitamins, flavonoids, quinones, polyphenols, amino acids, nucleic acids, essential fatty acids, cooling agents, binders, sweeteners, disintegrants, lubricants, colorants, flavorings, stabilizers, preservatives, sustained-release regulators, surfactants, dissolving agents, and wetting agents).
本実施形態に係る殺コロナウイルス剤は、固体、液体、ペースト等のいずれの形状であってもよく、タブレット(素錠、糖衣錠、発泡錠、フィルムコート錠、チュアブル錠、トローチ剤等を含む)、カプセル剤、丸剤、粉末剤(散剤)、細粒剤、顆粒剤、液剤、懸濁液、乳濁液、シロップ、ペースト、注射剤(使用時に、蒸留水又はアミノ酸輸液若しくは電解質輸液等の輸液に配合して液剤として調製する場合を含む)等の剤形であってもよい。これらの各種製剤は、例えば、プロポリスと、必要に応じて他の成分とを混合して上記剤形に成形することによって調製することができる。 The coronavirus killing agent according to this embodiment may be in any form, such as a solid, liquid, or paste, and may be in the form of a tablet (including plain tablets, sugar-coated tablets, effervescent tablets, film-coated tablets, chewable tablets, troches, etc.), capsule, pill, powder (dispersed agent), fine granules, granules, liquid, suspension, emulsion, syrup, paste, injection (including the case where it is mixed with distilled water or an infusion such as an amino acid infusion or an electrolyte infusion at the time of use to prepare it as a liquid), etc. These various preparations can be prepared, for example, by mixing propolis with other components as necessary and forming the mixture into the above-mentioned dosage form.
上記殺コロナウイルス剤は、医薬品、医薬部外品、食品組成物、又は化粧品そのものとして、又はこれらの製品中の成分として使用することができる。殺コロナウイルス剤を一成分として含む医薬品、医薬部外品、食品組成物、又は化粧品は、例えば、これら製品の製造工程における中間製品に、上記殺コロナウイルス剤を添加することにより製造することができる。 The above-mentioned coronavirus killer can be used as a medicine, quasi-drug, food composition, or cosmetic itself, or as an ingredient in these products. A medicine, quasi-drug, food composition, or cosmetic containing a coronavirus killer as an ingredient can be produced, for example, by adding the above-mentioned coronavirus killer to an intermediate product in the production process of these products.
本実施形態に係る殺コロナウイルス剤からなる医薬品、医薬部外品、食品組成物若しくは化粧品、又は、該殺コロナウイルス剤を含む医薬品、医薬部外品、食品組成物若しくは化粧品は、殺コロナウイルス用であってよい。これらの製品には、例えば、コロナウイルスを不活化する旨、コロナウイルスを分解する旨、コロナウイルスを破壊する旨、コロナウイルスを殺ウイルスする旨、コロナウイルスを除去する旨、コロナウイルスを抑制する旨等が表示されていてもよい。 A medicine, quasi-drug, food composition, or cosmetic comprising the coronavirus killing agent according to this embodiment, or a medicine, quasi-drug, food composition, or cosmetic containing the coronavirus killing agent, may be for killing coronaviruses. These products may be labeled, for example, to inactivate coronaviruses, decompose coronaviruses, destroy coronaviruses, kill coronaviruses, remove coronaviruses, suppress coronaviruses, etc.
本実施形態に係る殺コロナウイルス剤は、経口投与されてもよく、非経口により投与されてもよい。また、本実施形態に係る殺コロナウイルス剤は、皮膚外用剤であってもよい。殺コロナウイルス剤は、例えば、滴下、散布、塗布等の処置により、必要とする皮膚の部位に直接適用されてもよい。投与態様は、経口投与であってもよく、非経口投与であってもよい。本実施形態に係る殺コロナウイルス剤は、一日一回投与されてもよく、一日二回、一日三回等、複数回に分けて投与されてもよい。 The coronavirusicidal agent according to this embodiment may be administered orally or parenterally. The coronavirusicidal agent according to this embodiment may also be an external preparation for skin. The coronavirusicidal agent may be applied directly to the skin site where it is needed, for example, by treatment such as dripping, spraying, or painting. The mode of administration may be oral or parenteral. The coronavirusicidal agent according to this embodiment may be administered once a day, or in multiple divided doses, such as twice or three times a day.
化粧品には、動物(ヒトを含む)の皮膚、粘膜、体毛、頭髪、頭皮、爪、歯、顔皮、口唇等の部位に適用され得る、あらゆる化粧品が含まれる。 Cosmetics include any cosmetic product that can be applied to the skin, mucous membranes, body hair, head hair, scalp, nails, teeth, facial skin, lips, etc. of animals (including humans).
化粧品の剤形は、例えば、可溶化系、乳化系、粉末系、油液系、ゲル系、軟膏系、エアゾール系、水-油2層系、水-油-粉末3層系等であってよい。上記化粧品は、例えば、洗顔料、化粧水、乳液、クリーム、ジェル、エッセンス、美容液、パック、マスク、ミスト、UV予防化粧品等の基礎化粧品、ファンデーション、口紅、頬紅、アイシャドウ、アイライナー、マスカラ等のメークアップ化粧品、洗顔料、マッサージ用剤、クレンジング用剤、アフターシェーブローション、プレシェーブローション、シェービングクリーム、ボディソープ、石けん、シャンプー、リンス、へアートリートメント、整髪料、へアートニック剤、ヘアミスト、ヘアフォーム、ヘアリキッド、ヘアジェル、ヘアスプレー、育毛剤、制汗剤、入浴剤、マウスリンス、口腔化粧品、歯磨剤、ハンドクリーム、ハンドソープ、などであってよい。 The formulation of the cosmetic product may be, for example, a solubilized system, an emulsion system, a powder system, an oil liquid system, a gel system, an ointment system, an aerosol system, a water-oil two-layer system, a water-oil-powder three-layer system, etc. The above-mentioned cosmetic product may be, for example, a face wash, a lotion, a milky lotion, a cream, a gel, an essence, a beauty serum, a pack, a mask, a mist, a basic cosmetic product such as a UV protection cosmetic product, a make-up cosmetic product such as a foundation, a lipstick, a blusher, an eye shadow, an eyeliner, a mascara, etc., a face wash, a massage agent, a cleansing agent, an aftershave lotion, a preshave lotion, a shaving cream, a body soap, a soap, a shampoo, a rinse, a hair treatment, a hair styling product, a hair tonic agent, a hair mist, a hair foam, a hair liquid, a hair gel, a hair spray, a hair growth agent, an antiperspirant, a bath agent, a mouth rinse, an oral cosmetic product, a dentifrice, a hand cream, a hand soap, etc.
化粧品には、有効成分としてのプロポリス以外に、通常化粧品に用いられる成分、例えば、美白剤、保湿剤、酸化防止剤、油性成分、紫外線吸収剤、界面活性剤、増粘剤、アルコール類、粉末成分、色材、水性成分、水、各種皮膚栄養剤等を必要に応じて適宜配合することができる。 In addition to propolis as an active ingredient, cosmetics can contain other ingredients commonly used in cosmetics, such as whitening agents, moisturizers, antioxidants, oily ingredients, UV absorbers, surfactants, thickeners, alcohols, powdered ingredients, coloring materials, aqueous ingredients, water, various skin nutrients, etc., as needed.
本実施形態に係る殺コロナウイルス剤を含む化粧品の処方例としては、例えば、上記有効成分に加え、ダマスクバラ花水、蜂蜜、ローヤルゼリーエキス、ローズマリー葉エキス、ユズ果実エキス、メリッサ抽出液、ザクロ抽出液、ユーカリ抽出液、オリーブ葉抽出液等を含むものであってよく、更にエタノール、ベンチレングリコール、ブチレングリコール、グリセリン、水等を含むものであってよい。 Examples of formulations for cosmetics containing the coronavirus killer according to this embodiment may include, in addition to the above-mentioned active ingredients, rose damask flower water, honey, royal jelly extract, rosemary leaf extract, yuzu fruit extract, melissa extract, pomegranate extract, eucalyptus extract, olive leaf extract, etc., and may further include ethanol, pentylene glycol, butylene glycol, glycerin, water, etc.
殺コロナウイルス剤を食品組成物として又は食品組成物の一成分として用いる場合、該食品組成物は、食品の3次機能、すなわち体調調節機能が強調されたものであることが好ましい。食品の3次機能が強調された製品としては、例えば、健康食品、機能性表示食品、栄養機能食品、栄養補助食品、サプリメント及び特定保健用食品を挙げることができる。 When the coronavirusicide is used as a food composition or as one component of a food composition, it is preferable that the food composition emphasizes the tertiary function of food, i.e., the function of regulating physical condition. Examples of products that emphasize the tertiary function of food include health foods, functional foods, foods with nutritional functions, nutritional supplements, supplements, and foods for specified health uses.
食品組成物としては例えば、コーヒー、ジュース及び茶飲料等の清涼飲料、乳飲料、乳酸菌飲料、ヨーグルト飲料、炭酸飲料、並びに、日本酒、洋酒、果実酒及びハチミツ酒等の酒などの飲料;カスタードクリーム等のスプレッド;フルーツペースト等のペースト;チョコレート、ドーナツ、パイ、シュークリーム、ガム、ゼリー、キャンデー、クッキー、ケーキ及びプリン等の洋菓子;大福、餅、饅頭、カステラ、あんみつ及び羊羹等の和菓子;アイスクリーム、アイスキャンデー及びシャーベット等の氷菓;カレー、牛丼、雑炊、味噌汁、スープ、ミートソース、パスタ、漬物、ジャム等の調理済みの食品;ドレッシング、ふりかけ、旨味調味料及びスープの素等の調味料などが挙げられる。 Examples of food compositions include beverages such as soft drinks, such as coffee, juice, and tea drinks, milk drinks, lactic acid bacteria drinks, yogurt drinks, carbonated drinks, and alcoholic beverages, such as sake, Western liquor, fruit wine, and honey wine; spreads, such as custard cream; pastes, such as fruit paste; Western confectioneries, such as chocolate, donuts, pies, cream puffs, gum, jelly, candy, cookies, cakes, and puddings; Japanese confectioneries, such as daifuku, mochi, manju, castella, anmitsu, and yokan; frozen desserts, such as ice cream, popsicles, and sorbet; cooked foods, such as curry, beef bowl, porridge, miso soup, soup, meat sauce, pasta, pickles, and jam; and seasonings, such as dressings, furikake, umami seasonings, and soup bases.
以下、本発明を実施例に基づいてより具体的に説明する。ただし、本発明は以下の実施例に限定されるものではない。 The present invention will be described in more detail below with reference to examples. However, the present invention is not limited to the following examples.
<第一液:プロポリスエタノール抽出液の調製>
ブラジル産グリーンプロポリスのエタノール抽出液(固形分55%)に10倍量の水を加えて混合し、上清の水を除去した。その後、95%エタノールを更に加えて再溶解し、プロポリスの固形分が0.67%となるように調整することにより、第一液を調製した。
<First liquid: Preparation of propolis ethanol extract>
The ethanol extract of Brazilian green propolis (solid content 55%) was mixed with 10 times the amount of water, and the supernatant water was removed. Then, 95% ethanol was further added to redissolve the propolis, and the solid content of the propolis was adjusted to 0.67%, to prepare the first liquid.
<第二液の調製>
エタノール抽出後のプロポリス残渣に6倍量の水を加え混合し、90℃1時間加熱した。その後-20℃で凍結し、解凍した後、ろ過後固形分が3.0%になるように水で調整することにより、第二液を調製した。
<Preparation of second liquid>
The propolis residue after the ethanol extraction was mixed with 6 times the amount of water and heated at 90°C for 1 hour. It was then frozen at -20°C, thawed, and filtered, and the solid content was adjusted with water to 3.0%, to prepare a second liquid.
<サンプルの調製>
第一液:第二液:1,3-ブチレングリコール:ペンチレングリコール:水の質量比が1.8:10:9:3:36.2となるように混合したものをサンプルとした。サンプル全量に対して、第一液の固形分量は0.02%、第二液の固形分量は0.5%であった。
<Sample preparation>
The first liquid, the second liquid, and the 1,3-butylene glycol, pentylene glycol, and water were mixed in a mass ratio of 1.8:10:9:3:36.2 to prepare a sample. The solid content of the first liquid was 0.02% and the solid content of the second liquid was 0.5% relative to the total weight of the sample.
<殺ウイルス試験>
上記サンプルを10倍希釈した液1mLに、Porcine epidemic diarrhea virus P-5V株(豚感染性のコロナウイルス)0.1mLを添加し、室温(25℃)で2時間感作させた。試験液中のウイルス遺伝子を抽出し、リアルタイムPCRにてウイルス遺伝子検査を行い、Ct(Threshold Cycle)値を算出した。その結果、Ct値は20.6であり、ウイルス減少率は98.24%と推定された。
<Virucidal test>
0.1 mL of Porcine epidemic diarrhea virus P-5V strain (porcine infectious coronavirus) was added to 1 mL of a 10-fold diluted solution of the above sample, and the sample was sensitized at room temperature (25°C) for 2 hours. The viral genes in the test solution were extracted, and a viral gene test was performed by real-time PCR, and the Ct (Threshold Cycle) value was calculated. As a result, the Ct value was 20.6, and the virus reduction rate was estimated to be 98.24%.
対照実験として、精製水1mLに、Porcine epidemic diarrhea virus P-5V株(豚感染性のコロナウイルス)0.1mLを添加し、2時間後、試験液中のウイルス遺伝子を抽出し、リアルタイムPCRにてウイルス遺伝子検査を行い、Ct(Threshold Cycle)値を算出した。その結果、Ct値は15.0であり、ウイルス減少率は13.51%と推定された。
As a control experiment, 0.1 mL of Porcine epidemic diarrhea virus P-5V strain (porcine infectious coronavirus) was added to 1 mL of purified water, and after 2 hours, the viral genes in the test solution were extracted and subjected to a viral gene test by real-time PCR to calculate the Ct (Threshold Cycle) value. As a result, the Ct value was 15.0, and the virus reduction rate was estimated to be 13.51%.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020166179A JP7470412B2 (en) | 2020-09-30 | 2020-09-30 | Coronavirus killer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020166179A JP7470412B2 (en) | 2020-09-30 | 2020-09-30 | Coronavirus killer |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022057767A JP2022057767A (en) | 2022-04-11 |
JP7470412B2 true JP7470412B2 (en) | 2024-04-18 |
Family
ID=81110377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020166179A Active JP7470412B2 (en) | 2020-09-30 | 2020-09-30 | Coronavirus killer |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7470412B2 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102600457A (en) | 2011-12-22 | 2012-07-25 | 青岛绿曼生物工程有限公司 | Compound propolis composition used for treating pig viral diarrhea and preparation method thereof |
-
2020
- 2020-09-30 JP JP2020166179A patent/JP7470412B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102600457A (en) | 2011-12-22 | 2012-07-25 | 青岛绿曼生物工程有限公司 | Compound propolis composition used for treating pig viral diarrhea and preparation method thereof |
Non-Patent Citations (4)
Title |
---|
Evidence-Based Complementary and Alternative Medicine,,2018年,Vol.2018, Article ID 7092416,pp.1-9 |
Microbiologica,1990年,Vol.13,pp.207-213 |
Taky SS. et al.,Evaluation of Antiviral Activity of Bee Venom, Phospholipase A-2 (PLA-2) and Propolis against DNA and RNA Virus Models: In-Vitro Study,Inventi Rapid: Molecular Pharmacology,2017年,Vol.2017, No.2,pp.1-8 |
Virology Journal,2011年,Vol.8:460,pp.1-6,http://www.virologyj.com/content/8/1/460 |
Also Published As
Publication number | Publication date |
---|---|
JP2022057767A (en) | 2022-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3966922B2 (en) | Fibroblast growth promoter | |
JP3966924B2 (en) | Fibroblast growth promoter containing plant extract | |
CN108601762A (en) | Inflammatory body activates inhibitor | |
KR20190094913A (en) | Composition for preventing hair loss or reinforcing scalp comprising natural extract | |
KR20210014231A (en) | Composition for prevention or treatment of muscular disorders or improvement of muscular functions comprising seaweeds extract | |
WO2005094860A1 (en) | Agent improving peripheral blood flow | |
JP2005179308A (en) | Antiallergy composition | |
JP6981664B2 (en) | Nourishing tonic | |
JP2009203199A (en) | Hair-growing composition | |
KR102179610B1 (en) | Composition for preventing hair loss or promoting hair growth containing essential oil mixture of Coicis semen and Evening Primrose seeds | |
JP2014114216A (en) | Estradiol production promoter | |
JP2007314472A (en) | Body odor inhibiting agent | |
JP6902329B2 (en) | Inhibitor of sebaceous gland cell activation | |
JP7470412B2 (en) | Coronavirus killer | |
KR102315700B1 (en) | Composition for treating or preventing acne comprising elaeagnus umbellata leaves extract | |
JP2008106023A (en) | Estradiol production promotor | |
KR101897720B1 (en) | Cosmetic or pharmaceutical composition for promoting hair growth comprising Tenebrio molitor fractions | |
JP4169814B2 (en) | A topical skin preparation containing agave or sisal extract | |
KR101740970B1 (en) | Topical composition comprising the herbal mixed extract including phytoncide of Chamaecyparis obtusa showing hair-growth stimulating activity and preventing effect on hair loss | |
JP5537352B2 (en) | Hair growth inhibitor | |
JP2010270021A (en) | Ucp gene expression-promoting agent | |
JP2020132576A (en) | Sarcopenia obesity preventive/ameliorating agent | |
JP2022099508A (en) | Coronavirus killer | |
JP2008106029A (en) | Hyperoxidation inhibitor for lipid in living body | |
KR20160056655A (en) | Composition for inhibiting obesity comprising complex salt of baicalin and zinc |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221219 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231114 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231227 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240326 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240401 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7470412 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |